经济观察网 在国务院新闻办公室今天（5日）举行的新闻发布会上，市场监管总局介绍，2025年，组织 开展公平竞争审查抽查，敦促有关政策制定机关对妨碍统一市场和公平竞争的政策措施进行整改；查处 医药领域系列垄断案件，推动涉案药品大幅降价；查办各类反不正当竞争案件1.46万件。综合整治"内 卷式"竞争，加强对重点企业的成本调查、价格检查、约谈指导，有效推动"价格战""补贴战"及时降 温。 ...

国机重装：2025年度净利润同比增长10.89% 利亚德：拟不超1亿元投资产业基金，后者将定向投资商业航天（核心股）领域的非上市公司 【经营合作】 【增持回购】 长安汽车：拟以10亿元-20亿元回购公司股份 【业绩】 【重要事项】 股票频道更多独家策划、专家专栏，免费查阅>> 责任编辑：栎树 盛新锂能：全资子公司盛屯锂业拟12.6亿元收购惠绒矿业13.93%股权 广东建工：联合体中标15.24亿元年产2GWh三维固态锂电池（核心股）智能制造生产基地项目 中船防务：签订16艘支线集装箱船建造合同，金额7.36亿美元至8.96亿美元 中文在线：拟与腾讯计算机就动画微短剧授权合作事宜达成合作 东华科技：与青海东台吉乃尔锂资源股份有限公司签订战略合作框架协议 上海医药（核心股）：拟不低于10.23亿元公开挂牌转让中美施贵宝30%股权 中船防务：签订16艘支线集装箱船建造合同 金额7.36亿美元至8.96亿美元 银邦股份：收到Holtec公司约2.8亿元销售订单 斯莱克：控股子公司获韩国电池客户项目定点 惠博普：签订约15.96亿元Naft Khana油田复产项目合同 北新路桥：联合体中标11.45亿元工程项目 康恩贝 ...

Group 1 - Intercontinental Oil and Gas focuses on oil exploration and development, with significant operations in Kazakhstan and the Malacca Strait, benefiting from the Hainan Free Trade Port's zero-tariff policy which will reduce equipment import costs and enhance cross-border energy trade efficiency, with a projected 30% increase in trade scale over the next three years [1][34] - Jinpan Technology, a leading manufacturer of high-end power distribution equipment, will benefit from reduced raw material costs and a 15% corporate income tax reduction, enhancing profitability and enabling expansion into the ASEAN power equipment market [2][35] - Hainan Airlines, a major player in the aviation sector, expects a significant increase in passenger traffic due to the visa-free policy for 86 countries and duty-free upgrades, with projected passenger volume exceeding 80 million by 2026 [3][36] Group 2 - Junda Co., a top photovoltaic cell manufacturer, anticipates growth in its solar business due to reduced equipment costs and tax incentives, with plans to participate in Hainan's integrated wind and solar storage projects [4][37] - Caesar Travel, a comprehensive tourism service provider, expects a doubling of cross-border tourism business and a significant increase in tourist arrivals, with projections of 180 million visitors by 2026 [5][38] - Xinda A, a diversified company focusing on motorcycle manufacturing and coal mining, aims to leverage the zero-tariff policy to enhance profitability and expand into the electric vehicle market [6][39] Group 3 - ST Huluwawa, a leading pediatric pharmaceutical company, will benefit from reduced raw material costs and tax incentives, with plans to expand into the ASEAN pharmaceutical market [8][40] - Hainan Ruize, a construction industry leader, anticipates a surge in infrastructure demand with projected investments exceeding 100 billion by 2026, benefiting from the Hainan Free Trade Port's policies [9][42] - Hainan Airport, a key player in airport operations, expects a doubling of cargo business and significant passenger growth due to the visa-free policy and duty-free upgrades [10][43] Group 4 - Hainan Development, an investment platform, anticipates a substantial increase in duty-free sales, projected to exceed 100 billion by 2026, benefiting from the Hainan Free Trade Port's policies [11][45] - Hainan Highway, a major highway operator, expects a significant increase in traffic volume, projected to exceed 200 million vehicles by 2026, benefiting from the integration of tourism and real estate [20][56] - Hainan Rubber, the world's largest natural rubber producer, aims to expand its market presence in ASEAN due to favorable trade policies and tax incentives [21][57]

Group 1 - Changan Automobile plans to repurchase company shares with an investment of 1 billion to 2 billion RMB, with a repurchase price cap not exceeding 150% of the average trading price over the last 30 trading days before the board's approval [1] - Zhonggu Logistics intends to invest up to 1.16 billion RMB to construct two 6000 TEU container ships, aiming to enhance its competitive edge in container transportation [2] - Huibo Pu signed a contract worth 225 million USD (approximately 1.596 billion RMB) with NK Petroleum Company for the Naft Khana oilfield rehabilitation project, expected to positively impact the company's performance in 2026-2027 [3] Group 2 - ZTE Technology clarified that it is not involved in space photovoltaic business despite media reports, focusing instead on HJT solar cell products for ground applications [4] - ZTO Express forecasts its revenue for 2025 to be between 48.5 billion and 50 billion RMB, representing a growth of approximately 9.5% to 12.9% from 2024, driven by an increase in package volume [5] - Tiantong Co. announced it does not produce commercial satellites or optical module products, maintaining its focus on electronic materials and high-end specialized equipment [6] Group 3 - Guangdong Construction won a bid for a 1.524 billion RMB project to build a 2GWh three-dimensional solid-state lithium battery manufacturing base [7] - Jing Sheng Electric stated that the application scenarios for "space photovoltaic" are still in the exploratory phase, with significant uncertainties in the industrialization process [8][9] - Shuangliang Energy confirmed it has not engaged in space photovoltaic-related business, with its current products focused on polysilicon reduction furnace systems and high-efficiency solar modules [10] Group 4 - Vision China’s wholly-owned subsidiary plans to invest 1.7 million USD to subscribe for 56.67% of a fund managed by Wonderland International Asset Management, focusing on cutting-edge AI technologies [11] - Jinjing Technology noted that the TCO glass market is still relatively small, with minimal impact on its revenue from TCO glass sales expected in 2025 [12] - HeSteel Resources announced that its South African subsidiary has suspended underground mining due to severe flooding, which is expected to adversely affect the company's annual production and sales plan [13]

Suspension - Ruixin Technology plans to issue shares and pay cash for the control of Wuhu Deheng, leading to a suspension of trading starting tomorrow [1] Mergers and Acquisitions - Shengxin Lithium Energy's wholly-owned subsidiary, Shengtun Lithium Industry, intends to acquire a 13.93% stake in Huirong Mining for 1.26 billion yuan. Upon completion, the company will fully control Huirong Mining, which holds mining rights for the Muzhong Lithium Mine with confirmed Li2O resources of 989,600 tons and an average grade of 1.62%, making it one of the highest-grade lithium mines in Sichuan with a production capacity of 3 million tons per year [2] Share Buybacks and Increases - Changan Automobile plans to repurchase shares worth between 1 billion and 2 billion yuan [3] - Pianzaihuang's controlling shareholder has obtained a special loan commitment for a stake increase of no more than 450 million yuan [4] External Investments and Daily Operations - China Shipbuilding Defense has signed contracts for the construction of 16 feeder container ships, with a total contract value between 736 million and 896 million USD [5] - Xinquan Co., Ltd. plans to invest 42 million USD to establish a subsidiary in Malaysia through its wholly-owned subsidiary [6] - Yinbang Co., Ltd. has received a sales order from Holtec worth approximately 280 million yuan [7] - Beixin Road and Bridge has won a project bid worth 1.145 billion yuan [8] - Sileck's controlling subsidiary has been designated for a project by a South Korean battery customer [9] - Hongchang Technology plans to acquire a total of 21% equity in Liangzhi Joints from Rost and two individuals, aiming to hold 51% of Liangzhi Joints and become its controlling shareholder [9] - Guangdong Construction has won a bid for a project to produce 2GWh of three-dimensional solid-state lithium batteries in Yugan, Jiangxi, with a bid amount of 1.524 billion yuan [9] - Huibo Pu has signed a contract with NK Oil Company and its Iraqi branch for the Naft Khana oilfield restoration project, with a contract value of 225 million USD [9] - Guangyang Co., Ltd. has signed a strategic cooperation agreement with Shenzhen Xuan Chuang Robotics and Huangshan Guangyang Robotics to jointly develop, produce, and sell high-end special embodied products [9] - Chengzhi Co., Ltd.'s subsidiary Qingdao Chengzhi Huqing's ultra-high molecular weight polyethylene project has successfully entered trial production [10] - Zhonggu Logistics plans to sign a contract for the construction of two 6000 TEU container ships with China Merchants Jinling Shipyard, with a total contract amount not exceeding 1.16 billion yuan or its equivalent in USD [10] - Liard plans to invest up to 100 million yuan in a fund that will focus on investing in non-listed companies in the commercial aerospace sector [11] - Zhongwen Online intends to reach a cooperation agreement with Tencent Computer regarding the authorization of animated micro-short dramas [12]

Core Viewpoint - Jiangsu Wuzhong is divesting its wholly-owned subsidiary, Shanghai Wuzhong Meixue Biotechnology, for 80 million yuan, indicating a strategic shift to focus on its core pharmaceutical business and reduce investment in the medical aesthetics sector [1][2]. Group 1: Company Actions and Strategy - Jiangsu Wuzhong plans to transfer 100% equity of Shanghai Wuzhong Meixue to Shanghai Qingyu Biotechnology for 80 million yuan, based on the subsidiary's asset valuation [1]. - The company confirmed a reduction in R&D investment in the medical aesthetics segment, aiming to concentrate on its pharmaceutical core business [1][2]. - The medical aesthetics division, established in 2021, has a sales team of 55 covering 537 medical aesthetic institutions [3]. Group 2: Financial Performance - The medical aesthetics segment generated 3.3 billion yuan in revenue in 2024, a staggering increase of 4225.65% year-on-year, contributing 20% to Jiangsu Wuzhong's total revenue of 16 billion yuan [4]. - The company had previously secured exclusive distribution rights for the AestheFill product until August 2032, which significantly boosted revenue [3][4]. Group 3: Legal and Regulatory Issues - Jiangsu Wuzhong is currently involved in arbitration with REGEN over a breach of the exclusive distribution agreement, seeking to confirm the validity of the agreement and potential damages of 1.6 billion yuan [6]. - The company faces reputational damage due to allegations of securities law violations, which have impacted the sales of AestheFill in mainland China [5][6]. Group 4: Historical Context - Jiangsu Wuzhong's stock was delisted on December 31, 2025, due to inflated revenue figures totaling 1.8 billion yuan over four years, which constituted about 20% of reported income during that period [7].

Core Viewpoint - The company is actively advancing its GMP certification process for new production capacities and has successfully passed FDA certification, indicating a commitment to international quality standards and market-oriented quality management systems [1] Group 1: GMP Certification Progress - The company has established a comprehensive cGMP system at its Ma'anshan industrial base, which is crucial for regulatory compliance and operational efficiency [1] - The Shandong Heze industrial base has obtained ISO "three systems" certification, while the Jiangsu Qidong GMP production base has passed ISO 14001 and ISO 45001 certifications, enhancing its operational standards [1] - The Chongqing antibody-conjugated CDMO base successfully passed the EU QP audit in June 2025, meeting EU GMP standards, which supports its international GMP system development [1] Group 2: Future Plans and Customer Focus - The company aims to enhance its international GMP certification process and improve its ability to undertake high-end overseas product orders, driven by a customer value-oriented approach [1] - The company emphasizes continuous technological advancement and service optimization to better meet customer needs [1]

"怀北红肖梨很多都产自百年老树，坚持生态种植，创新制成了鲜炖小碗梨、梨茶、梨膏等产品。"工作 人员对红肖梨文化背景的介绍吸引了很多旅客驻足。朝阳区市民王红梅是红肖梨的老粉丝，她告诉记 者："我买的枇杷鲜炖小碗梨，小孩老人都喜欢吃。过年买回去清火，食补大于药补。" 针对春节送礼和聚会需求，北京御食园食品股份有限公司带来了丰富的零食与特产。非遗八珍糕、北京 桃酥等经典产品，既保留传统手艺，又有新意，让大家尝到正宗的老北京味儿。甘栗、桑葚山楂条等特 产，采用的都是怀柔本地优质农产品，让人们能够品味纯正的怀柔味道。 2月3日，我区精选多家具有代表性的特色企业，以"彰显怀柔特色、展现城市风采"为主题，在北京朝阳 站设立新春特色产品展销区。同时，联动京东中国特产馆·怀柔优品馆，搭建线上线下联动消费场景， 为返乡旅客与市民朋友献上一场集文化底蕴、品质好物与数字消费于一体的新春消费新体验。 上午10点，"北京最北、怀柔最美"展区内已经人头攒动。来自怀北镇的红肖梨系列小特精产品成为焦 点，工作人员热情地向顾客介绍产品："这是我们今年的新品，把小碗梨带回家，寓意着我们离不开幸 福，离不开团圆。" "上上签"趣味饼干，现场斩获众多 ...

得益于产品的认可度逐步提升与精细化的成本控制，中健康桥展现出了极强的盈利韧性。2022年至2024 年，公司营业收入从2.68亿元稳步增长至4.47亿元；主营业务毛利率更是连续三年保持在90%以上的高 位，2024年达到92.66%。更为关键的是，公司的账面利润具有极高的含金量，2024年归母净利润达1.03 亿元，同期经营活动产生的现金流量净额达到1.11亿元，这种利润与现金流的高度匹配，印证了公司作 为医药制造企业扎实的造血能力。 针对市场普遍关注的营收结构集中问题，中健康桥并未止步于单一爆款的红利，而是正在通过"研发 +并购"的双轮驱动策略，构建层次清晰的产品梯队以化解风险。在稳固铝镁匹林片(II)与银杏叶胶囊这 一国家基药品种构成的基盘市场的同时，公司积极通过外延式并购获取新的增长极，已成功收购盐酸阿 罗洛尔片和注射用夫西地酸钠的药品注册批件及相关技术。其中，盐酸阿罗洛尔片作为治疗高血压与心 绞痛的经典药物，与公司现有的心脑血管渠道高度协同；注射用夫西地酸钠则帮助公司切入了抗感染领 域。这种策略使得公司能够利用成熟的营销网络迅速导入新产品，打造第二增长曲线。 与此同时，中健康桥在自主研发端也保持着长期 ...

Core Viewpoint - The company has approved a comprehensive credit financing limit of up to RMB 650 million and a guarantee limit of up to RMB 600 million for itself and its subsidiaries, aimed at supporting business operations and development [2][5]. Group 1: Guarantee Adjustment Situation - The company has adjusted the unused guarantee limits of its subsidiaries, transferring a total of RMB 16 million to its wholly-owned subsidiary Hefei Yifan Pharmaceutical Co., Ltd. (合肥亿帆) [3]. - After the adjustment, the guarantee limits for Sichuan Defeng Pharmaceutical Co., Ltd., Anqing Xinfuhua Chemical Co., Ltd., and Xinfuhua Technology Co., Ltd. have been reduced to zero, while the limit for Hefei Yifan has increased from RMB 88 million to RMB 104 million [3]. Group 2: Guarantee Overview - The company signed an irrevocable maximum guarantee agreement with China Merchants Bank Hefei Branch, agreeing to provide a joint liability guarantee for Hefei Yifan's debts, with a maximum guarantee amount of RMB 10 million [4]. - The guarantee is valid for the duration of the loans or financing agreements under the credit agreement, extending three years beyond the maturity of each loan [9]. Group 3: Financial and Operational Context - Hefei Yifan, established on September 9, 2022, is a wholly-owned subsidiary of the company, with a registered capital of RMB 100 million and involved in various pharmaceutical and medical-related activities [6][7]. - The company has confirmed that Hefei Yifan is not a dishonest executor and has the capability to repay its debts [10]. Group 4: Cumulative Guarantee Situation - As of the report date, the total external guarantee balance of the company and its subsidiaries is RMB 5.132 billion, accounting for 60.22% of the company's audited net assets for 2024 [11].